NEXIEN BIOPHARMA, INC. Convertible Notes Payable, Current
NEXIEN BIOPHARMA, INC. had Convertible Notes Payable, Current of $170.45 thousand as of 2023-03-31, per its 10-Q filed 2023-05-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2023-05-17
- 2023-03-31: Convertible Notes Payable, Current $170.45K.
- 2022-12-31: Convertible Notes Payable, Current $167.65K.
- 2022-09-30: Convertible Notes Payable, Current $154.92K.
- 2022-06-30: Convertible Notes Payable, Current $142.18K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2023-03-31 | $170.45K 10-Q · filed 2023-05-17 |
| 2022-12-31 | $167.65K 10-Q · filed 2023-02-08 |
| 2022-09-30 | $154.92K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $142.18K 10-Q · filed 2023-05-17 |
| 2022-03-31 | $120.04K 10-Q · filed 2022-05-12 |
| 2022-01-18 | $142.18K 10-K · filed 2022-09-28 |
| 2021-12-31 | $23.80K 10-Q · filed 2022-02-08 |
| 2021-09-30 | $18.40K 10-Q · filed 2021-11-22 |
| 2021-06-30 | $12.94K 10-Q · filed 2022-02-08 |
| 2020-06-30 | $12.00K 10-K · filed 2021-10-12 |